Woodside's Browse stake to rise to 41.27%, subject to approvals Browse Australia's largest undeveloped conventional gas resource Shares of Woodside Energy down over 1.4% Browse is Australia's largest ...
After 80 years of fruitless struggle by human mathematicians, a major geometry conjecture has at last been solved—via a straightforward query to a chatbot. “No previous AI-generated proof has come ...
A new quantum-inspired algorithm has cracked a problem so massive that conventional supercomputers struggle to even approach it. Researchers used the method to simulate extraordinarily complex quantum ...
It’s hard to ignore the seismic shifts brought about by algorithm-driven content. Every time you scroll through your social media feed or check your favorite news app, algorithms are diligently at ...
House Republican leaders unveiled two new bills last week in the latest federal attempt to regulate data privacy, preempting states’ existing laws. House Republicans rolled out yet another proposal ...
Investor interest in Anthropic has reached a feverish pitch. The maker of the Claude AI assistant has received multiple preemptive offers to raise fresh capital of around $50 billion at a valuation in ...
Email has and continues to be one of the most widely targeted channels for cyber threats. While the need to secure it is nothing new, the tools and strategies needed to do so effectively have changed ...
Microsoft is lining up two very different Teams updates, and one of them targets a meeting problem almost everyone knows too well. The company is preparing a pre-join mic and speaker test that lets ...
Follow all of Saturday's NCAA Tournament second round games with USA TODAY Sports' live updates. PORTLAND, OR – As the mid-majors continue to succeed in the NCAA Tournament, the noise around the ...
Geography and regional rivalries have prevented Gulf countries from finding a true alternative to the strait, which the war with Iran has effectively shut down. By Rebecca F. Elliott and Vivian Nereim ...
In preclinical findings, the investigational new oral drug TIX100 completely prevented weight rebound in mouse models after semaglutide was stopped — a discovery that lays the groundwork for human ...